SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UBX) (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...

Title: Effect of Patient Baseline Characteristics on Response to UBX1325, a Novel Senolytic Candidate For Patients With DME: BEHOLD Phase 2 Study 48 weeks follow-up ...

The full Unity PSVR 2 presentation from GDC 2022 is now available to view online, and while there’s a lot to take away, it does hammer down just how much of a game-changer the likes of eye-tracking ...

John Riccitiello opened his company's GDC 2017 keynote in much the same style he has every major Unity presentation over the past few years: reiterating the company's three goals, one of which is ...